Advances in understanding of angioimmunoblastic T-cell lymphoma.

doi:10.1038/s41375-020-0990-y

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Advances in understanding of angioimmunoblastic T-cell lymphoma.

Leukemia - 1 Oct 2020

Chiba Shigeru, Sakata-Yanagimoto Mamiko

Abstract excerpt

It has been nearly half a century since angioimmunoblastic T-cell lymphoma (AITL) was characterized in the early 1970's. Our understanding of the disease has dramatically changed due to multiple discoveries and insights. One of the key features of AITL is aberrant immune activity. Although AITL is now understood to be a neoplastic disease, pathologists appreciated that it was an inflammatory condition. The more...

Topics

Animals
Humans
Immunoblastic Lymphadenopathy
Lymphoma, T-Cell
Mutation
Prognosis
Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 32704161
DOI: 10.1038/s41375-020-0990-y
PMCID: PMC7376827

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics